Related references
Note: Only part of the references are listed.Novel Agents for Metastatic Triple-Negative Breast Cancer: Finding the Positive in the Negative
Neelima Vidula et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2021)
Integrated molecular profiling of young and elderly patients with triple-negative breast cancer indicates different biological bases and clinical management strategies
Ding Ma et al.
CANCER (2020)
Predictors of Response and Survival Outcomes of Triple Negative Breast Cancer Receiving Neoadjuvant Chemotherapy
Meizhen Zhu et al.
CHEMOTHERAPY (2020)
Asia Consensus Statement on NCCN Clinical Practice Guideline for bladder cancer
Hiroyuki Nishiyama
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2018)
Androgen receptor in triple negative breast cancer: A potential target for the targetless subtype
L. Gerratana et al.
CANCER TREATMENT REVIEWS (2018)
The Clinical Significance of Breast-only and Node-only Pathologic Complete Response (pCR) After Neoadjuvant Chemotherapy (NACT) A Review of 20,000 Breast Cancer Patients in the National Cancer Data Base (NCDB)
Oluwadamilola M. Fayanju et al.
ANNALS OF SURGERY (2018)
Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer
Paul Gass et al.
BMC CANCER (2018)
The predictive value of Ki-67 before neoadjuvant chemotherapy for breast cancer: a systematic review and meta-analysis
Xianyu Chen et al.
FUTURE ONCOLOGY (2017)
Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy
N. Masuda et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Residual Pure Intralymphatic Breast Carcinoma Following Neoadjuvant Chemotherapy Is Indicative of Poor Clinical Outcome, Even in Node-Negative Patients
Esther Cheng et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2017)
Neoadjuvant therapy for triple negative and HER2-positive early breast cancer
Nadia Harbeck et al.
BREAST (2017)
ESO-ESMO 3rd international consensus guidelines for breast cancer in young women (BCY3)
Shani Paluch-Shimon et al.
BREAST (2017)
Androgen receptor expression predicts beneficial tamoxifen response in oestrogen receptor-α-negative breast cancer
Erik Hilborn et al.
BRITISH JOURNAL OF CANCER (2016)
Clinical verification of sensitivity to preoperative chemotherapy in cases of androgen receptor-expressing positive breast cancer
Yuka Asano et al.
BRITISH JOURNAL OF CANCER (2016)
Targeting the androgen receptor in triple-negative breast cancer
Ayca Gucalp et al.
CURRENT PROBLEMS IN CANCER (2016)
Tailoring therapies-improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
A. S. Coates et al.
ANNALS OF ONCOLOGY (2015)
Evolving Treatment Strategies for Triple-Negative Breast Cancer
Melinda Telli
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2015)
Nomograms in oncology: more than meets the eye
Vinod P. Balachandran et al.
LANCET ONCOLOGY (2015)
Standardization of pathologic evaluation and reporting of postneoadjuvant specimens in clinical trials of breast cancer: recommendations from an international working group
Elena Provenzano et al.
MODERN PATHOLOGY (2015)
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
Patricia Cortazar et al.
LANCET (2014)
Ki67 levels as predictive and prognostic parameters in pretherapeutic breast cancer core biopsies: a translational investigation in the neoadjuvant GeparTrio trial†
C. Denkert et al.
ANNALS OF ONCOLOGY (2013)
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
A. Goldhirsch et al.
ANNALS OF ONCOLOGY (2013)
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
Antonio C. Wolff et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
The prognostic significance of lymphovascular invasion in invasive breast carcinoma
Emad A. Rakha et al.
CANCER (2012)
Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
A. Goldhirsch et al.
ANNALS OF ONCOLOGY (2011)
Factors influencing survival in patients with breast cancer and single or solitary brain metastasis
A. Niwinska et al.
EJSO (2011)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Measurement of residual breast cancer burden to predict survival after Neoadjuvant chemotherapy
W. Fraser Symmans et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Share Paper
